Literature DB >> 2861505

Treatment of childhood Raynaud's disease by transdermal prostaglandin E2 analogue.

D B Dunger, M J Dillon, C Daman-Willems, E D Cooke, S A Bowcock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2861505     DOI： 10.1016/s0140-6736(85)90108-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Managing Raynaud's phenomenon.

Authors:  S Roath
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

2.  Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

Authors:  M Rademaker; R H Thomas; G Provost; J A Beacham; E D Cooke; J D Kirby
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

Review 3.  Management of Raynaud's phenomenon. Focus on newer treatments.

Authors:  S Roath
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.